Deleteriousness scores calculated using CADD revealed several variants with very high scores, including those in RGPD3, LRP1B, and RET, emphasizing their critical roles in thyroid cancer progression and therapeutic potential (Rentzsch et al., 2019; Schubach et al., 2024). This evidence concerns the gene RGPD3 and thyroid gland carcinoma.